CRF's independent Angiographic Core Lab (ACL) has over 20 years of experience in coronary and peripheral angiographic analyses, including an assessment of the appropriateness for performing percutaneous procedures (eg, stent implantation) as well as an assessment of the quality of results of such procedures. CRF's services include but are not limited to:
- Quantification of lesion severity: Does the lesion meet the minimum standard criteria for stent implantation?
- Assessment of lesion morphology: Does the lesion have unstable features (eg, presence of thrombus)?
- Assessment of the overall complexity of coronary artery disease (ie, Syntax Score): Is the overall severity of the disease such that CABG would have better outcomes than PCI?
- Assessment of the quality of the PCI procedure; Quantification of acute angiographic results and assessment of angiographically documented complications
The CTC can also perform independent case assessment and review using NYC area practicing, interventional and noninterventional cardiologists as well as other specialists as required.The reviews factor in symptoms, physical exams, ECG, laboratory values, non-invasive testing, serial studies, procedural IVUS and other patient related information. These panels are experienced in assessing procedural indications, complications, and patient outcomes, and whether adverse outcomes are related to specific cardiovascular procedures.
Analysis can be customized depending on client needs. We look forward to working with you.
For more information on PCI appropriateness criteria, CRF's Clinical Trials Center and how we can work together click here.
If you have questions or would like additional information about the PCI Appropriateness Evaluation, please contact Sarah Luijpers at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or 646-434-4136.
